All News Glenmark Life Sciences Limited Bombay S.E.

Equities

GLS

INE03Q201024

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-05-03 am EDT			5-day change	1st Jan Change
829.4 ^INR	-1.40%		+1.91%	+26.23%

Apr. 25	Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024
Apr. 25	Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024	Apr. 25
Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	Apr. 25	CI
Glenmark Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024	Apr. 25	CI
Glenmark Life Sciences Limited Announces Resignation of Gita Nayyar as Non-Executive, Independent Director	Apr. 22	CI
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.	Mar. 11	CI
Glenmark Life Sciences Limited Announces Board Resignations, Effective March 6, 2024	Mar. 06	CI
Nirma Limited completed the acquisition of 0.000738% stake in Glenmark Life Sciences Limited.	Feb. 28	CI
Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24	Feb. 15	AQ
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs	Feb. 14	RE
Transcript : Glenmark Life Sciences Limited, Q3 2024 Earnings Call, Jan 24, 2024	Jan. 23
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	Jan. 23	RE
Glenmark Life Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 23	CI
Paracetamol maker Granules India posts marginal rise in Q3 profit	Jan. 23	RE
Glenmark Life Signs Master Supply Agreement with Japanese Drugmaker for Urinary Anti-Spasmodic API	Jan. 19	MT
Glenmark Life Sciences Announces Another CDMO Deal	Jan. 18	CI
India's Glenmark Pharma posts Q2 loss on exceptional legal costs	Nov. 10	RE
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	Nov. 09	RE
Transcript : Glenmark Life Sciences Limited, Q2 2024 Earnings Call, Oct 20, 2023	23-10-20
India's Glenmark Life Sciences posts Q2 profit rise on API boost	23-10-20	RE
Glenmark Life Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Glenmark Life Sciences Limited Bombay S.E.

Equities

GLS

INE03Q201024

All News

Filters